CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the Company's investigational ...
Avance Clinical Showcases Early Phase Expertise and the Australian Advantage for EU Biotechs at BIO-Europe ViennaHelping European Biotechs Accelerate Early Phase Success With Faster Timelines, Lower ...
Revolutionizing Diagnostic PrecisionThe global AI in ultrasound imaging market is poised for impressive growth, projected to expand at a CAGR of around 22% over the next five years. This surge is ...
In the past few years, China’s pharmaceutical industry has begun to attract worldwide attention. Headlines now speak of “China’s biotech boom” and “global firms licensing Chinese drugs.” While some ...
MALMÖ, SE / ACCESS Newswire / November 3, 2025 / Ascelia Pharma (STO:ACE) - Ascelia Pharma AB (publ) (ticker:ACE), a biotech focused on improving the life of people living with rare cancer conditions, ...
The Needle-Free Injection System Market represents a groundbreaking advancement in medical technology, offering an innovative alternative to traditional needle-based drug delivery methods. These ...
The Rising Wave of Esoteric Testing The Esoteric Testing Market represents a specialized segment of diagnostic laboratory services that focuses on rare and complex tests not routinely performed in ...
In the rapidly evolving landscape of global pharmaceuticals, China has emerged as a formidable player, transitioning from a dominant producer of generic drugs to a hub for innovative medicines. Over ...
STOCKHOLM, SE / ACCESS Newswire / November 3, 2025 / Vicore Pharma Holding (STO:VICO) - Stockholm, November 3, 2025 - Vicore Pharma Holding AB (publ)(STO:VICO), unlocking the potential of a novel ...
The global market for anti-infective vaccines is entering a period of robust growth, driven by mounting infectious-disease burden, rising immunisation awareness and accelerating vaccine platform ...
TURKU, FI / ACCESS Newswire / November 3, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Having achieved all primary endpoints and secured FDA alignment, Faron formally concludes enrolment of ...
STOCKHOLM, SE / ACCESS Newswire / November 3, 2025 / iZafe Group (STO:IZAFE-B) - iZafe Group AB (publ.) today, November 3, presents its report for the third quarter.Summary of financial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback